In patients with T2D, metabolic stress promotes insulin resistance and activation of IkB kinase-β (IKKβ) and JUN N-terminal kinase (JNK), which suggests that these kinases have key roles in the pathogenesis of this disease [8]. The gene discussed is MAPK8; the disease is Insulin resistance.